Literature DB >> 10336924

Evaluation of myocardial, hepatic, and renal perfusion in a variety of clinical conditions using an intravenous ultrasound contrast agent (Optison) and second harmonic imaging.

J Hancock1, H Dittrich, D E Jewitt, M J Monaghan.   

Abstract

OBJECTIVE: To assess the potential of intravenous Optison, a second generation ultrasound contrast agent, and various ultrasound imaging modes to determine myocardial, kidney, and liver perfusion in normal subjects and patients with left ventricular dysfunction or chronic pulmonary disease together with renal or hepatic dysfunction.
METHODS: Five normal subjects and 20 patients underwent grey scale echocardiographic imaging of myocardium, kidney, and liver during 505 intravenous injections of Optison. Images were assessed qualitatively by two independent observers and quantitatively using video densitometry to determine the peak contrast enhancement effect.
RESULTS: Qualitative analysis showed that intermittent harmonic imaging was superior to either conventional fundamental or continuous harmonic imaging for all organs. Quantitative analysis showed that the peak change in echocardiographic intensity v baseline during continuous harmonic imaging was 11 units for myocardium (p < 0.03), 7 units for kidney (NS), and 14 units for liver (p < 0.05). During intermittent harmonic imaging the peak change was significantly greater, being 33 units for myocardium (p < 0.0001), 24 units for kidney (p < 0.0002), and 16 units for liver (p < 0.001).
CONCLUSIONS: Organ tissue perfusion can be demonstrated following intravenous injection of Optison, particularly when used in combination with intermittent harmonic imaging techniques. This contrast agent is effective in a variety of clinical conditions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336924      PMCID: PMC1729064          DOI: 10.1136/hrt.81.6.636

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  17 in total

1.  Renal, hepatic, and cardiac enhancement on Doppler and gray-scale sonograms obtained with EchoGen.

Authors:  T Albrecht; D O Cosgrove; J M Correas; L Rallidis; P Nihoyanopoulos; N Patel
Journal:  Acad Radiol       Date:  1996-08       Impact factor: 3.173

2.  New developments in ultrasound systems for contrast echocardiography.

Authors:  S Kaul
Journal:  Clin Cardiol       Date:  1997-10       Impact factor: 2.882

3.  Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.

Authors:  D M Skyba; G Camarano; N C Goodman; R J Price; T C Skalak; S Kaul
Journal:  J Am Coll Cardiol       Date:  1996-11-01       Impact factor: 24.094

4.  Second harmonic imaging of an intravenously administered echocardiographic contrast agent: Visualization of coronary arteries and measurement of coronary blood flow.

Authors:  S L Mulvagh; D A Foley; B C Aeschbacher; K K Klarich; J B Seward
Journal:  J Am Coll Cardiol       Date:  1996-05       Impact factor: 24.094

5.  On the feasibility of real-time, in vivo harmonic imaging with proteinaceous microspheres.

Authors:  F Forsberg; B B Goldberg; J B Liu; D A Merton; N M Rawool
Journal:  J Ultrasound Med       Date:  1996-12       Impact factor: 2.153

6.  Ultrasound contrast agents in liver imaging.

Authors:  E Leen; C S McArdle
Journal:  Clin Radiol       Date:  1996-02       Impact factor: 2.350

7.  Echo-enhancing agents in the renal tract.

Authors:  J Jakobsen
Journal:  Clin Radiol       Date:  1996-02       Impact factor: 2.350

8.  Ultrasound contrast enhancement of tumours.

Authors:  D Cosgrove
Journal:  Clin Radiol       Date:  1996-02       Impact factor: 2.350

9.  Harmonic imaging with ultrasound contrast agents.

Authors:  P N Burns
Journal:  Clin Radiol       Date:  1996-02       Impact factor: 2.350

10.  NHLBI funding policies. Enhancing stability, predictability, and cost control.

Authors:  C Lenfant
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

View more
  5 in total

1.  Assessment of tissue perfusion by contrast-enhanced ultrasound.

Authors:  Emilio Quaia
Journal:  Eur Radiol       Date:  2010-10-07       Impact factor: 5.315

2.  Second harmonic imaging: a new ultrasound technique to assess human brain tumour perfusion.

Authors:  J U Harrer; L Mayfrank; M Mull; C Klötzsch
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-03       Impact factor: 10.154

3.  Characterization of focal hepatic lesions with contrast-enhanced C-cube gray scale ultrasonography.

Authors:  Wen-Ping Wang; Hong Ding; Qing Qi; Feng Mao; Zhi-Zhang Xu; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

4.  Motion corrected cadence CPS ultrasound for quantifying response to vasoactive drugs in a rat kidney model.

Authors:  Rachel E Pollard; Paul A Dayton; Katherine D Watson; Xiaowen Hu; Ismayil M Guracar; Katherine W Ferrara
Journal:  Urology       Date:  2009-07-09       Impact factor: 2.649

5.  Noninvasive assessment of antenatal hydronephrosis in mice reveals a critical role for Robo2 in maintaining anti-reflux mechanism.

Authors:  Hang Wang; Qinggang Li; Juan Liu; Cathy Mendelsohn; David J Salant; Weining Lu
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.